Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-09-05), Forian's share price is $2.17. Forian's Tangible Book per Share of Mar. 2026 for the quarter that ended in Mar. 2026 was $0.83. Hence, Forian's Price to Tangible Book Ratio of today is 2.61.
The historical rank and industry rank for Forian's Price-to-Tangible-Book or its related term are showing as below:
FORA'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.05 Med: 3.54 Max: 292.67
Current: 2.61
During the past 7 years, Forian's highest Price to Tangible Book Ratio was 292.67. The lowest was 2.05. And the median was 3.54.
FORA's Price-to-Tangible-Book is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.65
vs FORA: 2.61
A closely related ratio is called PB Ratio. As of today, Forian's share price is $2.17. Forian's Book Value per Sharefor the quarter that ended in Mar. 2026 was $0.86. Hence, Forian's P/B Ratio of today is 2.52.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Forian Price-to-Tangible-Book Related Terms
Forian Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Forian's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FORA vs DRIO, ONMD, BEAT: Price-to-Tangible-Book Comparison
For the Health Information Services subindustry, Forian's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forian Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Forian's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Forian's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Forian (FORA) has a Price-to-Tangible-Book of 2.61 as of Sep. 05, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Forian and its competitors.
Is Forian's Price-to-Tangible-Book too high?
Forian's current Price-to-Tangible-Book is 2.61. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.65. Forian's value of 2.61 is 1.5% below this industry median. Overall, Forian has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Forian's Price-to-Tangible-Book compare to DRIO and ONMD?
Forian's Price-to-Tangible-Book of 2.61 can be compared against companies in the Healthcare Providers & Services industry. The industry median Price-to-Tangible-Book is 2.65. Forian's value of 2.61 is 1.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.65, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forian's current Price-to-Tangible-Book of 2.61 is 1.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Forian and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forian's current Price-to-Tangible-Book is 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forian stock overvalued right now?
Forian (FORA) has a current Price-to-Tangible-Book of 2.61. The stock's GF Value™ is $3.27, compared to a current price of $2.17 — trading 33.6% below its estimated fair value. The current Price-to-Tangible-Book is 2.61 and 1.5% below the Healthcare Providers & Services industry median of 2.65. Forian's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Forian (FORA), the current Price-to-Tangible-Book is 2.61 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Forian (FORA) Overvalued in 2026?
Based on GuruFocus' analysis, Forian stock appears to be undervalued.
The current stock price of $2.17 is trading 33.6% below its estimated GF Value™ of $3.27.
Key valuation signals for FORA:
Price-to-Tangible-Book: 2.61
GF Value™: $3.27 vs. price of $2.17 (33.6% below fair value)
Industry Position: 1.5% below the Healthcare Providers & Services median
No single metric tells the full story. See the FORA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
46GF Score
Get the complete analysis for FORA
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FORA has been successfully added to your 
